“…Piperidines are very important structural building blocks of numerous biologically active compounds, such as the Topo inhibitor, the Chk1 inhibitor, Tiagabine and Focalin XR [1]. The catalytic hydrogenation of pyridines provides one of the most straightforward methods to access piperidines [2,3,4,5,6,7,8,9,10,11,12,13,14,15,16,17,18], although it is essential to overcome some inherent challenges presented by catalyst deactivation and pyridine dearomatization. In the last decade, various transition-metal catalyst systems have been studied for the direct hydrogenation of pyridines, but the metal-free catalytic reduction of pyridines is a great challenge [19,20,21,22,23,24].…”